Prevalence of positive SteatoTest, NashTest and FibroTest in the chronic obstructive pulmonary disease (COPD) population, based on Global Initiative for Chronic Obstructive Lung Disease (GOLD) grades
| COPD GOLD grades | Total | p-value | |||
| I | II | III–IV | |||
| Patients n | 17 | 66 | 28 | 111 | |
| Positive SteatoTest | 2 (11.8) | 31 (47.0) | 13 (46.4) | 46 (41.4) | 0.026 |
| Positive NashTest | 5 (29.4) | 25 (37.9) | 11 (39.3) | 41 (36.9) | 0.777 |
| Positive FibroTest | 8 (47.1) | 44 (66.7) | 16 (57.1) | 68 (61.3) | 0.293 |
Data are presented as n (%), unless otherwise stated. Data presented in bold type are statistically significant.